Q2 2015 Holdings
Filed 2015-08-14 | 126 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | COM | 00287Y109 | $965.8M | 14,373,538 | 35.9% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $857.8M | 20,481,442 | 31.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $560.1M | 4,095,247 | 20.8% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $172.8M | 11,577,299 | 6.4% |
| Cerus Corporation(CERS) | COM | 157085101 | $70.3M | 13,553,275 | 2.6% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $30.3M | 7,335,692 | 1.1% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $11.1M | 100,000 | 0.4% |
| Aurinia Pharmaceuticals Inc.(AUPH) | COM | 05156V102 | $2.1M | 711,499 | 0.1% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $1.8M | 100,000 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADR | 15117K103 | $1.8M | 50,000 | 0.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.8M | 100,000 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $1.5M | 14,865,559 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $1.5M | 30,870,262 | 0.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $1.4M | 11,340 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.2M | 6,542,599 | 0.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $1.1M | 142,000 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | $567.8K | $274,500,000 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | $529.5K | $259,000,000 | 0.0% |
| Incyte Corporation Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | $478.8K | $40,446,000 | 0.0% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $379.5K | 13,657,598 | 0.0% |
| Anacor Pharmaceuticals, Inc. | COM | 032420101 | $280.7K | 3,625,498 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $210.1K | 7,926,630 | 0.0% |
| BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $150.0K | $22,379,000 | 0.0% |
| Gilead, Inc. 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $107.9K | $20,944,000 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $97.5K | 6,554,967 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $89.1K | 4,190,594 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $88.3K | 2,805,074 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $87.5K | 2,807,784 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $76.1K | 1,262,382 | 0.0% |
| Medivation, Inc. 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $75.0K | $33,889,000 | 0.0% |
| Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | $60.0K | $59,583,000 | 0.0% |
| Xoma Corporation | COM | 98419J107 | $57.0K | 14,683,513 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $55.5K | 1,862,019 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $52.3K | 3,436,585 | 0.0% |
| Alder Biopharmaceuticals Inc.(ALDR1EUR) | COM | 014339105 | $47.2K | 891,688 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $43.6K | 1,931,057 | 0.0% |
| aTyr Pharma Inc.(LIFEUSD) | COM | 002120103 | $43.2K | 2,335,125 | 0.0% |
| XenoPort, Inc. | COM | 98411C100 | $39.9K | 6,508,622 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $39.5K | 5,482,505 | 0.0% |
| Insmed, Inc.(INSM) | COM | 457669307 | $38.7K | 1,583,490 | 0.0% |
| Sangamo BioSciences, Inc.(SGMO) | COM | 800677106 | $35.8K | 3,230,932 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $33.4K | 2,320,424 | 0.0% |
| TG Therapeutics, Inc.(TGTX) | COM | 88322Q108 | $33.2K | 2,003,991 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $32.5K | 4,350,808 | 0.0% |
| Gilead Sciences, Inc.(GILD) | COM | 375558103 | $29.3K | 249,995 | 0.0% |
| Kythera Biopharmaceuticals, Inc. | COM | 501570105 | $29.2K | 387,741 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $25.9K | 542,236 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM | 45168K306 | $25.9K | 6,970,902 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $25.4K | 151,105 | 0.0% |
| Derma Sciences, Inc. | COM | 249827502 | $24.8K | 3,457,841 | 0.0% |